Disclosure of interest: Natalia Ciobanu: nothing to discose Poster Session I - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.02 - ACUTE MANAGEMENT - Thrombolysis or thrombectomy P056 - ESOC25-1418 HEALTH-ECONOMIC ANALYSIS OF THE FLYING INTERVENTION TEAM AS A NEW STROKE CARE SYSTEM IN RURAL AREAS Marie Coors 1 , Nikolai Hubert 2 , Tobias Bock 1 , Leonie Sundmacher 1 , Gordian Hubert 2 1 Department of Health Economics, Technical University of Munich, Munich, Germany, 2 TEMPiS Telemedical Stroke Center, Department of Neurology, Munich Clinic, Munich, Germany Background and Aims: Rapid treatment of ischaemic stroke reduces impairments, but rural interhospital patient transfers are associated with delays
Lokalreaktionen kommen bei Etanercept in 37 Prozent und bei Adalimumab in 20 Prozent der Flle vor
But here's the thing no one tells you up front: what happens when you stop taking it
Specifically, a few ingredients with low OB or DL were chosen as candidate ingredients because of their high bioactivity according to the literature